Cape Investment Advisory’s iShares Biotechnology ETF IBB Stock Holding History

Cape Investment Advisory’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Buy	+654	New	+$112K	0.03%	305
2026 Q1	–	Sell	-671	Closed	-$113K	–	641
2025 Q4	$113K	Buy	671 +595	+783%	+$96.6K	0.03%	284
2025 Q3	$11K	Sell	76 -1	-1%	-$136	0.01%	392
2025 Q2	$9.74K	Hold	77	–	–	﹤0.01%	640
2025 Q1	$9.85K	Hold	77	–	–	﹤0.01%	604
2024 Q4	$10.2K	Hold	77	–	–	﹤0.01%	586
2024 Q3	$11.2K	Hold	77	–	–	﹤0.01%	543
2024 Q2	$10.6K	Hold	77	–	–	﹤0.01%	509
2024 Q1	$10.6K	Sell	77 -100	-56%	-$13.7K	﹤0.01%	537
2023 Q4	$24K	Buy	177 +100	+130%	+$12.2K	0.01%	496
2023 Q3	$9.42K	Hold	77	–	–	0.01%	561
2023 Q2	$9.78K	Hold	77	–	–	0.01%	560
2023 Q1	$9.95K	Buy	+77	New	+$10.1K	0.01%	541

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Cape Investment Advisory's IBB Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 654 shares worth $124K. The stake represents 0.03% of the portfolio and ranks #305 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in IBB as recently as Q4 2025.

Cape Investment Advisory first reported a position in IBB in Q1 2023 and has held it in 13 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Cape Investment Advisory held 654 shares of iShares Biotechnology ETF worth $124K as of Q2 2026.
iShares Biotechnology ETF was a new Cape Investment Advisory position in Q2 2026.
iShares Biotechnology ETF made up 0.03% of Cape Investment Advisory's portfolio in Q2 2026, its #305 holding.
Cape Investment Advisory first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 13 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.